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Abstract
Background: Many articles have been written on conflicts of interests (COIs) in fields such as medicine, business, 
politics, public service and education. With the growing abundance of Public Private Partnerships (PPPs), often 
involving complex relationships among the partners, it is important to understand how COIs can be mitigated and 
managed in PPPs.
Discussion: We wanted to study PPPs, particularly in the areas of global health and agriculture, but discovered no 
single source of information available to identify and compare various approaches for avoiding and managing COIs in 
PPPs. This is a significant gap, especially for those wishing to study, compare and strengthen existing COI policies 
related to PPPs. In order to bridge this gap, we reviewed how PPPs currently address COIs and highlight what might be 
considered good practice in developing COI policies. We reviewed the online COI policies of 10 PPPs in global health 
and agriculture, and interviewed two global health PPP chief executives.
Summary: Based on our review of policies and interviews, we conclude that there exists a range of good practices 
including attention to accountability and governance, acknowledgement and disclosure, abstention and withdrawal, 
reporting and transparency, and independent monitoring. There appears to be a need for PPPs to interact closely and 
learn from each other on these parameters and to also place more emphasis on independent external monitoring of 
COIs as a means of strengthening their major social objectives on which their activities are largely predicated. We also 
recommend the establishment of a web based database, which would serve as a forum to discuss COI issues and how 
they can be resolved.
Background
Conflicts of interest (COIs) have been defined as involv-
ing a "set of conditions in which professional judgments
concerning a primary interest (such as a patient's welfare
or validity of research) tends to be unduly influenced by a
secondary interest (such as financial gain)" [1]. COIs can
pertain to individuals or entire institutions, and can be
financial or non-financial. Much has been written on
COIs in fields such as medicine, business, politics, public
service, and education. However, little if any guidance has
been provided on the methods for managing COIs within
the Public Private Partnerships (PPPs) operating in global
health and agriculture. Since partnerships between public
(by which we mean non profit) and private (by which we
mean for profit) organizations will invariably raise issues
of COI, the recognition and management of these COIs is
critical to the existence of these partnerships.
There are many PPPs operating in health and agricul-
ture. Product Development PPPs (PD-PPPs) like the
Medicines for Malaria Venture or the TB Alliance, assist
in the development of novel health products to tackle dis-
eases in the developing world. Access PPPs, such as The
Global Fund for AIDS, Tuberculosis and Malaria
(GFATM) or the Global Alliance for Vaccines and Immu-
nization (GAVI), have the goal of improving access to
treatments by providing funding mechanisms for pur-
chase of existing drugs or vaccines. Similarly, PPPs, which
operate in the field of agriculture like the Maize and
Wheat Improvement Centre (CIMMYT), the Interna-
tional Institute of Tropical Agriculture (IITA), World
Agroforestry Centre (ICRAF), African Agricultural Tech-
nology (AATF), International Potato Centre (CIP) and
Bioversity International (BI) work to develop, through
research, novel seedlings and agricultural practices to
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alleviate hunger and improve farming practices in differ-
ent parts of the world. The dozens of PPPs working in
these fields include "small single product collaborators
with industry to large entities hosted in UN agencies of
private not-for-profit organizations" [2-5].
Usually, these partnerships are created because the pri-
vate and public sector partners realize their inability to
single-handedly solve the multifaceted problems con-
fronting society. However, there is also the notion that
private companies, especially in the healthcare sector,
where many PD-PPPs and Access PPPs operate, partici-
pate in PPPs, in order to seek "future profits or markets or
to control the agenda of international agencies" [6,7].
With billions of dollars flowing through PPPs aiming to
improve the health of the global poor or to alleviate hun-
ger through the development of new farming techniques,
there is a lot at stake if these primary interests were to be
undermined or even seen to be undermined. This is espe-
cially true since the trust existing among the partners in a
multi-stakeholder organization is a key component of its
activities, which enables it to function. The existence of
trust among the partners helps to accentuate their sense
of commitment to the achievement of the aims and
objectives of the PPP and this also helps to facilitate the
effective implementation of any COI policy within the
organization.
To examine how PPPs address COIs, we reviewed the
websites of PPPs which are active in global health and
agriculture to describe the suggested practices and guid-
ance contained in their COI policies and in some cases
requested these policies (see Table 1). We also examined
their websites and interviewed the chief executives of the
Human Hookworm Vaccine Initiative of the Sabin Vac-
cine Institute (Sabin-HHVI) and PATH. Our objective
was to understand in depth how PPPs currently address
COIs. Given the heterogeneity, this was not a compre-
hensive survey of every PPP, but rather an attempt to
highlight actual practices.
These findings will be of interest to the public and pri-
vate stakeholders who are involved in PPPs in global
health and agriculture, as well as the broader global
health and agriculture communities who rely on these
organizations for novel products and improved access.
Discussion
Accountability and Governance
Accountability is at the core of every conflict of interest.
Dennis Thompson, who has written extensively on con-
flicts of interest, argues that accountability encompasses
reliance on the good character and by extension, good
judgment of the decision marker(s), regulation by a pro-
fessional body, regulation by government(s) through leg-
islation, and finally, a disclosure of conflicting interests.
To ensure accountability, PPPs have boards that supervise
their activities. Board members are expected to be indi-
viduals who epitomize integrity and who would put the
aims and objectives of the organization uppermost in
their minds when making decisions, which could affect
the success of the PPP. This standard of decision making
is expected even when there are other competing inter-
ests, which may influence or affect the decision-making
progress of the organization.
For example, Sabin-HHVI is a health PD-PPP based at
the Sabin Vaccine Institute (SABIN). SABIN is affiliated
with the Department of Microbiology, Immunology, and
Tropical Medicine of George Washington University
(GWU) and uses the laboratories there to conduct
research into the development of vaccines for hookworm
and other neglected tropic diseases. The President of
SABIN-HHVI is also the chairperson of the Department
of Microbiology, Immunology, and Tropic Medicine at
GWU. During our discussion with the President of
SABIN-HHVI, we learned that to prevent any potential
COI, two meetings are held annually between representa-
tives of SABIN and GWU in order to review potential or
perceived conflicts, and in addition SABI-HHVI employs
the services of an attorney from their board to help man-
age COI issues which might arise.
Acknowledgement and Disclosure of Possibility of Conflict 
of Interest
The acknowledgement of the possibility of conflicts of
interest was present in all policies we reviewed. These
policies are available on the websites of the PPPs. The
CEOs of HHVI and GAVI, whom we interviewed, both
agreed that as multi-stakeholder organizations, conflicts
of interest within PPPs are sometimes inevitable and this
should be acknowledged. We also discovered that PPPs
must not only be alert to actual conflicts of interest but
also to perceived ones, since these too can undermine
trust amongst the stakeholders in a PPP.
We can illustrate this point with the example of PATH,
an international nonprofit organization dedicated to the
development of appropriate health technologies and
which is closely associated with multiple PD-PPPs with
over 60 companies. During our review of PATH's COI
policy [8], we found out that an annual disclosure of COI
is mandatory for board members and employees in
Finance, Legal Affairs, Procurement and program staff in
a position to meaningfully influence the structure or
details of any particular public-private partnership. These
employees are also required to fill out disclosure forms
annually in a bid to identify and address individual con-
flict of interests. For instance, through this procedure,
PATH employees who own stock in companies where
PATH is involved in a business or financial relationship
are expected to disclose such holdings.
The PATH "Guiding Principles" document provides
definitions for concepts such as bias and conflict of inter-
est, and discusses issues of actual and perceived conflictsO
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Table 1: An Overview of Conflict of Interest Policies of Selected Procurement and PD-PPPs
Publisher Date of 
Publication
Conflict of Interest Definition Conflict of Interest (COI) Guidelines External 
Monitoring 
(from a source 
outside the PPP)
Website
PUBLIC-PRIVATE PARTNERSHIPS
PATH 12/2005 The conflict between the private interests and 
official responsibilities of an individual or an 
institution in a position of trust, which may 
compromise impartiality or integrity or lead 
to unfair competitive advantage
Guiding Principles for Managing COI
Values
1. Disclosure
2. Transparency
3. Respect
4. Support
5. Options
Responsibilities
1. Acknowledgement
2. Accountability: individual COI
1. Accountability: institutional COI
Actions
1. Training staff
2. External monitoring
3. Internal monitoring
No http://www.path.org
(general)
http://www.path.org/files/
ER_gp_conflict.pdf
(COI specific)
Global Alliance for 
Vaccines and 
Immunization
(GAVI)
03/2006 A conflict of interest arises whenever the 
personal or professional interests of an 
employee or board member are potentially at 
odds with the best interests of the 
organization.
The GAVI secretariat hires Procurement 
Expert(s) to:
1. Address COI issues as related to procurement
2. Link up with broader policy on COI
Yes, on some 
issues 
procurement 
experts provided.
http://www.gavialliance.org/
resources/
jec_23mar2006_AF2.ProcPrince.
pdf
GAVI 06/2000 See above GAVI applies specific conflict of interest policies to 
its different partners. For example, WHO/UNICEF 
are requested to complete a 'conflict of interest 
form' when executing contracts and participating 
in meetings.
See above http://www.gavialliance.org/
resources/oslo_annex2.docO
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The Global Fund 08/2005 A conflict of interest arises when a Covered 
Individual participates personally or 
substantially in an official capacity in any 
particular matter in which, to his or her 
knowledge, he or she or an Associated Person 
or Institution has a financial interest, if the 
particular matter will have a direct and 
predictable effect on that interest.
Transparency and Disclosure
- all covered individuals have a duty to disclose the 
existence of any conflict of interest and the nature 
of such conflict
- all covered individuals must complete and submit 
the "Declaration of Interest" to the Secretariat
- disclosure statements shall be updated annually 
and whenever there is a material change in the 
information they contain
- all conflict of interest are immediately disclosed to 
a Ethics and Conflict of Interest Committee
No http://www.theglobalfund.org/
documents/policies/
PolicyonEthicsandConflictofInter
estforGlobalFundInstitutions.pdf
International Maize 
and Wheat 
Improvement 
Centre (CIMMYT)
02/2008 N/A Operational Guidelines for Assessing the 
Impact of Agricultural Research on Livelihoods
"A conflict of interest should be dealt with openly 
and transparently so as not to compromise the 
reliability and credibility of the process and the IA 
results"
No http://www.aec.msu.edu/fs2/
zambia/sweet/
CIMMYT_impact_assessment_
guidelines_Rovere-
Dixon_2007.pdf (CIMMYT COI 
policy)
http://www.cgiar.org/impact/
research/maize.html (CGIAR 
information on Maize)
http://dtma.cimmyt.org/
(Drought Tolerant Maize for 
Africa Project)
IITA 05/1995 All matters which may tend to interfere with 
the Member's ability to participate in the 
activities of the Governing Board in a 
disinterested manner.
Policy
1. During consideration of any proposed 
commitment of funds of IITA to a beneficiary, any 
trustee who is formally connected with any 
interested party shall indicate that connection and 
withdraw from all related activities
2. No member of the board, other than the director 
general, shall enter into a direct contract with IITA
Implementation
- letters will be sent to individuals considered for 
election to membership to advice them of the 
policy so that they may consider whether they are 
prepared to undertake the obligations required.
No IITA is a CGIAR research centre 
that has done extensive work on 
maize including developing a 
"Drought Tolerant Maize for 
Africa" project with CIMMYT. 
http://www.iita.org/cms/details/
maize_project_details.aspx?zon
eid=63&articleid=273 (IITA work 
on maize)
http://dtma.cimmyt.org/
(Drought Tolerant Maize for 
Africa Project)
http://www.iita.org/cms/
articlefiles/306-conflict.pdf
(COI Policy)
Table 1: An Overview of Conflict of Interest Policies of Selected Procurement and PD-PPPs (Continued)O
m
o
b
o
w
a
l
e
 
e
t
 
a
l
.
 
B
M
C
 
I
n
t
e
r
n
a
t
i
o
n
a
l
 
H
e
a
l
t
h
 
a
n
d
 
H
u
m
a
n
 
R
i
g
h
t
s
 
2
0
1
0
,
 
1
0
:
1
9
h
t
t
p
:
/
/
w
w
w
.
b
i
o
m
e
d
c
e
n
t
r
a
l
.
c
o
m
/
1
4
7
2
-
6
9
8
X
/
1
0
/
1
9
P
a
g
e
 
5
 
o
f
 
8
World Agroforestry 
Centre (ICRAF)
03/2004 N/A The policy only mentions conflict of interest once 
as ICRAF seems to place minimal emphasis on 
conflict of interest within research.
No http://
www.worldagroforestry.org/
downloads/
policies%20and%20guidelines/
ICRAF_policy_research_ethics.pdf
African 
Agricultural 
Technology 
Foundation (AATF)
11/2006 N/A "Operational risks
2. Conflicts of interest at Board or partner level: 
Board members will be appointed in their personal 
capacity and not as representative of their 
institution. AATF Management shall periodically 
conduct partnership analysis and take appropriate 
action when cases of conflict of interest are 
identified."
Yes http://www.aatf-africa.org/
UserFiles/File/
strategicdirection1.pdf (AATF 
Strategy document)
AATF 2008 N/A "These [public-private] partnerships are usually 
governed by agreements that attempt to identify 
and articulate shared risks and are viewed as 
separate from stakeholders"
Yes http://www.aatf-africa.org/
partnerships
Consultative Group 
on International 
Agricultural 
Research (CGIAR)
CGIAR provides a legal and symbolic role and 
a statement to set and reinforce ethical 
standards, values, policies and basic 
responsibilities of individual board members
Some examples of the mandate:
- To maintain organizational integrity and 
guarantee that the actions of the Boards are in the 
best interests of the Center, Board Members need 
to understand their collective and individual 
responsibilities to avoid conflict of interest
- Ensure that the Center has in place policies 
needed for effective performance (including 
conflict of interest)
-Individuals should avoid conflict of interest, 
declare potential conflicts ahead of meetings, and 
recuse himself or herself from Board debates and 
decisions on matters for which he or she has a 
conflict
CGIAR's policy is targeted to board members. 
Guidelines for individual employees or the 
institution's values itself could not be found. The 
annex at the back of the document includes a 
sample self-assessment checklist for CGIAR Boards 
and Board Members.
No http://www.cgiar.org/
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Convention of 
Biological Diversity
2006 The policy on the webpage (or in hardcopy) is 
much more extensive than the overview of 
the guidelines given here.
This PPP's COI policy states that "it would be almost 
impossible to foresee the different circumstances 
under which conflict of interest could possibly 
arise, and that there was limited experience of 
compliance mechanisms under other international 
instruments in elaborating what constitutes 
conflict of interest, or in handling practical cases of 
conflicts of interest.
The rational given for this position is that there is 
already a procedure of compliance which requires 
members to serve objectively and in a personal 
capacity, which taken together with rules of 
procedure provide general guidelines to conflict of 
interest.
No http://www.cbd.Int
International 
Potato Centre (CIP)
N/A CIP has an external review system comprised 
of two parts. Center Commissioned External 
Reviews (CCERS) which originate with the 
board of trustees and Internally 
Commissioned External Reviews (ICERS) 
which originate from management.
The reasons for commissioning a review can be 
many including:
"The desire of the Board or management to have an 
external opinion of the status, relevance, quality or 
direction of a particular set of activities. 
Interestingly, the selection of any board members 
who want to participate in the reviews must take 
into account possible conflicts of interest they may 
have with the reviewing process or subject matter
Yes http://www.cipotato.org/
Bioversity 
International
N/A Bioversity International has a whistle-blower 
policy which protects individuals who 
whistle-blow, provides guidance for how and 
where to report instances of wrongdoing 
including conflict of interest.
The policy is unique in that it protects individuals 
who report other employees' conflicts of interest. 
Most policies only cover the obligation of 
employees to report and manage risks of possible 
conflict of interests in their own actions, rather than 
that of their fellow employees. The Whistle-Blower 
Policy provides the purpose, definition and 
applicability of the policy. It provides guidance to 
individual employees on what and when to report, 
what reporting channels are available, and their 
rights for feedback and protection.
No http://
www.bioversityinternational.org
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of interest, individual and institutional conflicts of inter-
est, as well as the direct and predictable effects of con-
flicts of interest. The "Guiding Principles" document for
managing COIs is divided into three parts, namely, "our
values", "our responsibilities" and "our actions". In the
s e c o n d  s e c t i o n ,  " o u r  r e s p o n s i b i l i t i e s " ,  P A T H  a c k n o w l -
edges that there might be occasions when some measure
of bias, inherent in its activities as a non-profit organiza-
tion, might precipitate individual or institutional conflicts
of interest. When such situations occur, the guiding prin-
ciples stipulate immediate individual or institutional
acknowledgement. The concepts of "Disclosure" as well
as "Reporting and Transparency", which are also dis-
cussed below, are closely aligned with "Acknowledgement
of Possibility of Conflict of Interest".
For a PD-PPP like the Medicines for Malaria Venture
(MMV), disclosure of potential conflict of interest is an
actual part of the employee's contract. Employees must
sign conflict of interest declaration forms, which spell out
perceived or potential, as well as real, sources of conflicts.
With an organization like GAVI, as with many others, a
conflict of interest arises when the personal or profes-
sional interests of an employee or board member, or
indeed of its partners, are at odds with the best interests
of the organization. In order to successfully pursue this
policy, GAVI also applies specific COI policies to its dif-
ferent partners [9]. For example, representatives of GAVI
and partners like the World Health Organization (WHO)
and the United Nations Children Emergency Fund (UNI-
CEF) are required to complete a COI disclosure form
when executing contracts or participating in meetings
where decisions for the procurement of drugs and vac-
cines are being taken [9]. For the Global Fund (GF), a COI
arises when a "covered individual", that is someone who
works directly with GF or is associated with GF, partici-
pates personally in taking decisions on any matter which
affects GF and from which he or she might benefit. When
this happens, GF expects all covered individuals to dis-
close the existence of any such conflict and the nature of
such conflict. Secondly, all covered individuals must
complete and submit a "Declaration of Interest" state-
ment, which must be updated annually to GF's Ethics and
Conflict of Interest Committee [10].
Abstention and Withdrawal from Decision Making Process
The COI policies of several PPPs, operating within the
field of agricultural biotechnology like the Maize and
Wheat Improvement Centre (CIMMYT), the Interna-
tional Institute of Tropical Agriculture (IITA), World
Agroforestry Centre (ICRAF), African Agricultural Tech-
nology (AATF), Convention on Biological Diversity
(CBD), International Potato Centre (CIP) and Bioversity
International (BI), which all receive funding from the
Consultative Group on International Agricultural
Research (CGIAR) state that apart from disclosing any
conflicts of interest, individuals working for these organi-
zations could elect to recuse themselves when decisions
are taken on issues or organizations in which they have a
secondary interest.
The IITA and CGIAR COI policies stipulate that board
members are expected to formally declare their connec-
tion with any organization that would benefit from the
organization's funding and withdraw from any decision
that would be taken about matters concerning such a
beneficiary [11,12].
Training
Most of the PPPs that we surveyed require their employ-
ees to undergo periodic training on how to identify and
avoid or manage COIs. The PATH COI policy talks about
PATH's responsibility to train its staff to recognize con-
flict of interest situations as well as subject itself to inter-
nal and external monitoring to prevent conflicts of
interest within the organization. The policy also indicates
that the process of minimizing conflicts of interest must
begin with the development of a mechanism to balance
the conflicting interests of the parties involved in the
partnership.
Whistle Blowing, Public Reporting and Transparency
Beyond disclosure of a COI internally, some policies also
featured public transparency of such COIs and ways to
stimulate reporting of COI. For example, CIMMYT's
COI guidelines emphasizes that a COI issue must be dealt
with in an open and transparent manner that would not
compromise the integrity and credibility of the organiza-
tion [13]. Biodiversity International has a whistle blower
policy, which actually encourages employees to secretly
report instances of wrongdoing, which include COI by
colleagues [14]. In the case of Global Fund, reports of
COI occurrences are posted on its website.
Independent Monitoring
Relatively few of the organizations use independent,
external monitoring of COI, though there are some
exceptions. The GAVI secretariat uses consultants who
examine every potential COI with regards to procure-
ment. The International Potato Centre uses a two tier
external and internal review system to monitor all deci-
sions and to prevent COI. The COI policies of several of
the PPPs that we have reviewed rely on external monitors
to assist in the prevention and detection of potential
COIs. External monitoring is an effective way of continu-
ing to reinforce trust among the partners of a multi-
stakeholder organization; it helps to maintain an organi-
zation's ethical commitments. Though monitoring can be
done internally or externally, external monitoring has the
advantage of providing an independent and unbiased
evaluation. An analogy here is financial auditing: anOmobowale et al. BMC International Health and Human Rights 2010, 10:19
http://www.biomedcentral.com/1472-698X/10/19
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external financial audit offers an independent view on the
finances of an organization and thereby serves to enhance
the trustworthiness of the annual financial report. An
organization that adopts a social auditing system of ethi-
cal and social monitoring and reporting can do so for a
single domain (like conflict of interest). However, a more
comprehensive, multifaceted approach to monitoring
that involves all the activities that the organization is
involved in might be more effective.
Conclusion
Managing COIs is a critical governance and management
function for PPPs. Based on our review of COI policies
and the interviews that we conducted, a range of good
practices was found. These included attention to
accountability and governance, acknowledgement and
disclosure of COIs, abstention and withdrawal from deci-
sion-making when a COI is present, reporting and trans-
parency with respect to COIs, and independent
monitoring.
One area that could perhaps use more focus, since it is
at the frontier of the various approaches, is the use of
external, independent monitoring. Though some PPPs
have employed the services of external monitors to pro-
vide guidance and assistance on COI issues, these moni-
tors are not usually fully cognizant of the activities of
these PPPs, a situation which compromises the integrity
of the external monitoring system. Most external moni-
tors are called in to provide advice on conflicts after it has
already occurred. Thus, in order to protect these PPPs,
there may be a need to better manage COIs through inte-
grating the services of 'an outside non-conflicted party'
[15]. This outside non-conflicted party, (external moni-
tor) could help to scrutinize, mitigate, and provide com-
prehensive guidance on ethical, social, cultural and
commercialization issues by undertaking periodic assess-
ments, while working alongside the team itself, by helping
to assess policies and decisions and give objective advice
throughout the partnership's progress. (Of course, the
external monitor should not be doing other work for the
organization that might seem to be dependent on the
outcome of the monitoring.) We believe that this kind of
system is a good way to help mitigate COIs within almost
every area of activity in PPPs. In our work with an agri-
culture PPP, we conducted an external social audit [16].
It could be fruitful for PPPs to learn from each other on
management of COI, and to move down the spectrum of
policies and practices identified here towards indepen-
dent monitoring of COIs. It might also be useful for this
independent monitoring to extend beyond COI to other
social objectives of the partnership.
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